Johns Hopkins makes major investment in the power, promise of data science and artificial intelligence bit.ly/3Ksp0Nz via The Hub

cendigitalmagazine.acs.org/2023/08/11/cen…?

RayzeBio plans IPO to push radiotherapy 'pipeline-in-a-product' through phase 3 fiercebiotech.com/biotech/rayzeb…

Australian R&D spending drops as percentage of GDP shar.es/agn3nI

Eli Lilly hops aboard for Mariana Oncology's $175M series B, radiopharmaceuticals mission fiercebiotech.com/biotech/eli-li…

No more needles, an oral insulin medication could be on the horizon - Advanced Science News advancedsciencenews.com/no-more-needle…

Blackstone's $250M bet beats Xarelto in bleeding trial, making case for Anthos' ex-Novartis asset fiercebiotech.com/biotech/blacks…

'Quantum therapeutic' triggers glioblastoma cells to self-destruct fiercebiotech.com/research/quant…

Novartis targets first-line use for radiotherapy Lutathera after trial win in neuroendocrine tumors fiercepharma.com/pharma/novarti…

Incidental CAC missed in CT chest scans: study: thelimbic.com/cardiology/inc…

Roche's BTK inhibitor may have reached 'holy grail' of brain penetration in phase 2 MS trial fiercebiotech.com/biotech/roches…

ESMO: As peers enter radiopharmaceuticals, Novartis says welcome to the party fiercebiotech.com/biotech/esmo-p…

We are only 3 weeks away from the VBIC Annual Network Meeting!! Be sure to seize this opportunity to join fellow researchers and industry partners in Victoria's imaging community. Register now to secure your spot: eventbrite.com.au/e/victoria-bio…

Just over a week until the VBIC Annual Network Meeting! Don't miss out on this opportunity to hear about the latest innovations in imaging research, as well as industry and commercialisation insights! Secure your spot now- eventbrite.com.au/e/691502120457

AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field fiercepharma.com/pharma/abbvie-…

UPDATE: Roche muscles in on obesity market with $2.7B Carmot buyout, securing injectable and oral assets fiercebiotech.com/biotech/roche-…

Scalable human embryo model displays earliest stages of blood cell production fiercebiotech.com/research/scala…

Wishing everyone a wonderful festive season, fortunate to work and collaborate with such amazing people everyday, all the best for 2024.

Longboard’s shares triple as epilepsy med halves seizure rates in early-stage trial fiercebiotech.com/biotech/longbo…

As historic MDMA decision nears, even J.P. Morgan eyes psychedelic investments fiercebiotech.com/biotech/jp-mor…